Literature DB >> 12022223

Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions.

José L Walewski1, Julio A Gutierrez, Westyn Branch-Elliman, Decherd D Stump, Toby R Keller, Alfredo Rodriguez, Gary Benson, Andrea D Branch.   

Abstract

The RNA genome of the hepatitis C virus (HCV) undergoes rapid evolutionary change. Efforts to control this virus would benefit from the advent of facile methods to identify characteristic features of HCV RNA and proteins, and to condense the vast amount of mutational data into a readily interpretable form. Many HCV sequences are available in GenBank. To facilitate analysis, consensus sequences were constructed to eliminate the overrepresentation of certain genotypes, such as genotype 1, and a novel package of sequence analysis tools was developed. Mutation Master generates profiles of point mutations in a population of sequences and produces a set of visual displays and tables indicating the number, frequency, and character of substitutions. It can be used to analyze hundreds of sequences at a time. When applied to 255 HCV core protein sequences, Mutation Master identified variable domains and a series of mutations meriting further investigation. It flagged position 4, for example, where 90% or more of all sequences in genotypes 1, 2, 4, and 5, have N4, whereas those in genotypes 3, 6, 7, 8, 9, and 10 have L4. This pattern is noteworthy: L (hydrophobic) to N (polar) substitutions are generally rare, and genotypes 1, 2, 4, and 5 do not form a recognized super family of sequences. Thus, the L4N substitution probably arose independently several times. Moreover, not one member of genotypes 1, 2, 4, or 5 has L4 and not one member of genotypes 3, 6, 7, 8, 9, or 10 has N4. This nonoverlapping pattern suggests that coordinated changes at position 4 and a second site are required to yield a viable virus. The package generated a table of genotype-specific substitutions whose future analysis may help to identify interacting amino acids. Three substitutions were present in 100% of genotype 2 members and absent from all others: A68D, R74K, and R114H. Finally, this study revealed thatARFP, a novel protein encoded in an overlapping reading frame, is as conserved as conventional HCV proteins, a result supporting a role for ARFP in the viral life cycle. Whereas most conventional programs for phylogenetic analysis of sequences provide information about overall relatedness of genes or genomes, this program highlights and profiles point mutations. This is important because determinants of pathogenicity and drug susceptibility are likely to result from changes at only one or two key nucleotides or amino acid sites, and would not be detected by the type of pairwise comparisons that have usually been performed on HCV to date. This study is the first application of Mutation Master, which is now available upon request (http://tandem.biomath.mssm.edu/mutationmaster.html).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022223      PMCID: PMC1370277          DOI: 10.1017/s1355838202029023

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  58 in total

1.  In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep.

Authors:  Nelson Acosta-Rivero; Julio C Alvarez-Obregón; Alexis Musacchio; Viviana Falcón; Santiago Dueñas-Carrera; Jeny Marante; Ivón Menéndez; Juan Morales
Journal:  Biochem Biophys Res Commun       Date:  2002-01-11       Impact factor: 3.575

2.  Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein.

Authors:  A Machida; H Ohnuma; F Tsuda; E Munekata; T Tanaka; Y Akahane; H Okamoto; S Mishiro
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

3.  Amino acid substitution matrices from protein blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

5.  Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase.

Authors:  W Lu; A Strohecker; J H Ou Jh
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

6.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.

Authors:  E A Brown; H Zhang; L H Ping; S M Lemon
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

8.  Internal ribosome entry site within hepatitis C virus RNA.

Authors:  K Tsukiyama-Kohara; N Iizuka; M Kohara; A Nomoto
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.

Authors:  M Martell; J I Esteban; J Quer; J Genescà; A Weiner; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Expression and identification of hepatitis C virus polyprotein cleavage products.

Authors:  A Grakoui; C Wychowski; C Lin; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  18 in total

Review 1.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

2.  Cell-mediated immune responses directed against hepatitis C virus (HCV) alternate reading frame protein (ARFP) are undetectable during acute infection.

Authors:  Christian Drouin; Stéphanie Lamarche; Julie Bruneau; Hugo Soudeyns; Naglaa H Shoukry
Journal:  J Clin Virol       Date:  2009-12-01       Impact factor: 3.168

3.  Structural analysis of hepatitis C RNA genome using DNA microarrays.

Authors:  María Martell; Carlos Briones; Aránzazu de Vicente; María Piron; Juan I Esteban; Rafael Esteban; Jaime Guardia; Jordi Gómez
Journal:  Nucleic Acids Res       Date:  2004-06-24       Impact factor: 16.971

4.  Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.

Authors:  Maureen J Donlin; Nathan A Cannon; Rajeev Aurora; Jia Li; Abdus S Wahed; Adrian M Di Bisceglie; John E Tavis
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

5.  Seroconversion to hepatitis C virus alternate reading frame protein during acute infection.

Authors:  Yoann Morice; Maxime Ratinier; Ahmed Miladi; Stéphane Chevaliez; Georgios Germanidis; Heiner Wedemeyer; Syria Laperche; Jean-Pierre Lavergne; Jean-Michel Pawlotsky
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

6.  Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma.

Authors:  Sarah L Fishman; Stephanie H Factor; Cinzia Balestrieri; Xiaofeng Fan; Adrian M Dibisceglie; Suresh M Desai; Gary Benson; Andrea D Branch
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

7.  Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms.

Authors:  Francis J Eng; Jose L Walewski; Arielle L Klepper; Sarah L Fishman; Suresh M Desai; Laura K McMullan; Matthew J Evans; Charles M Rice; Andrea D Branch
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

8.  Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy.

Authors:  Maureen J Donlin; Nathan A Cannon; Ermei Yao; Jia Li; Abdus Wahed; Milton W Taylor; Steven H Belle; Adrian M Di Bisceglie; Rajeev Aurora; John E Tavis
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

9.  Evidence for action of ribavirin through the hepatitis C virus RNA polymerase.

Authors:  N A Cannon; M J Donlin; L M Mayes; A C Lyra; A M Di Bisceglie; J E Tavis
Journal:  J Viral Hepat       Date:  2009-02-23       Impact factor: 3.728

10.  A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication.

Authors:  Shihyun You; Decherd D Stump; Andrea D Branch; Charles M Rice
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.